94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
Jun Li1,2†
Sile Han1†
Cuiyun Zhang1,2
Yanlin Luo3Li Wang3
Ping Wang4Yi Wang5Qingxin Xia5Xiaoyan Wang1,2Bing Wei1,2Jie Ma1,2Hongle Li1,2*
Yongjun Guo1,2*- 1Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China
- 2Henan Key Laboratory of Molecular Pathology, Zhengzhou, China
- 3Department of Gynecologic Oncology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China
- 4Department of Pathophysiology, School of Basic Medical Science, Zhengzhou University, Zhengzhou, China
- 5Department of Pathology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China
A Corrigendum on:
Identification of BRCA1: c.5470_5477del as a Founder Mutation in Chinese Ovarian Cancer Patients
by Li J, Han S, Zhang C, Luo Y, Wang L, Wang P, Wang Y, Xia Q, Wang X, Wei B, Ma J, Li H and Guo Y (2021). Front. Oncol. 11:655709. doi: 10.3389/fonc.2021.655709
In the original article, we neglected to include the funder National Natural Science Foundation of China, 81802779 to Jun Li; Henan Provincial Health Commission, SBGJ202002020 to Jun Li; and Henan Science and Technology Project, 212102310675 to Jun Li.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: BRCA1/2, haplotype analysis, ovarian cancer, founder mutation, Chinese
Citation: Li J, Han S, Zhang C, Luo Y, Wang L, Wang P, Wang Y, Xia Q, Wang X, Wei B, Ma J, Li H and Guo Y (2022) Corrigendum: Identification of BRCA1:c.5470_5477del as a Founder Mutation in Chinese Ovarian Cancer Patients. Front. Oncol. 11:840551. doi: 10.3389/fonc.2021.840551
Received: 21 December 2021; Accepted: 22 December 2021;
Published: 14 January 2022.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2022 Li, Han, Zhang, Luo, Wang, Wang, Wang, Xia, Wang, Wei, Ma, Li and Guo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yongjun Guo, Z3VveW9uZ2p1bkB6enUuZWR1LmNu; Hongle Li, bGxobDczQDE2My5jb20=
†These authors have contributed equally to this work and share first authorship